Healthcare

Cancer treatment can save lives, yet some of the most effective chemotherapies carry a hidden cost to the heart. This tension sits at the centre of a clinical question now explored by Racura Oncology Limited (ASX: RAC), a Sydney-based Phase 3 clinical-stage biopharmaceutical company. …

For investors following Australian clinical-stage biotechnology, the language of early cancer trials can feel impenetrable. Terms such as dose escalation, BOIN and maximum tolerated combined dose describe the machinery that determines whether a drug candidate advances or stalls. Racura Oncology (ASX: RAC) has given …

Racura Oncology Limited (ASX: RAC) is a clinical-stage biopharmaceutical company whose stated mission is to "silence cancer". One of its programs addresses a problem that has shadowed cancer medicine for decades: the heart damage caused by some of the most effective chemotherapy drugs ever …

Racura Oncology Limited (ASX: RAC) has secured a moment on the international stage. The Sydney-based, clinical-stage biopharmaceutical company confirmed that its abstract describing the CPACS study of RC220 combined with doxorubicin has been accepted for a poster presentation at the 2026 Global Cardio-Oncology Summit. …

Racura Oncology Limited (ASX: RAC) is a Phase 3 clinical-stage biopharmaceutical company with the stated mission to "silence cancer". Much of the market attention around clinical-stage biotechnology gravitates toward trial data and regulatory milestones, yet the way a company communicates its strategy to investors …

Racura Oncology Limited (ASX:RAC) has released an early but closely watched update from its CPACS Phase 1 program, and the headline is deliberately understated: no dose-limiting toxicities were recorded in the first cohort of patients. A data point this early does not prove a …

For investors following Racura Oncology Limited (ASX:RAC), the company's calendar for August 2026 has become a focal point. Rather than a single data release, the month features two scheduled investor engagements: a morning briefing in Auckland, and a presentation at a long-running biotechnology summit …